Neogen acquires Scidera Genomics
Neogen Corporation has acquired the assets of Scidera Genomics, an animal genomics business based in Davis, California. The company, formerly operated as MetaMorphix, Inc., or MMI Genomics, was a pioneer in the development of cattle, poultry, swine, and canine genetic testing.
Scidera’s predecessor company conducted parentage testing and trait analysis for the cattle and canine industries since DNA was first used in the early 1990s. The company owns critical patents and other intellectual property in the industry. Scidera also has had successful long-term customer relationships with influential dog breed registries, including the American Kennel Club, and numerous cattle breed associations, including the American Akaushi Association and American Bucking Bull, Inc.
“Scidera’s highly respected technical staff and customer base represent a perfect complement to Neogen’s animal genomics businesses, GeneSeek and Igenity,” said Dr. Jason Lilly, Neogen’s vice president of corporate development. “The combination of these companies within Neogen creates the unquestioned global leader in innovative animal genomics tools and analysis.”
The acquisition, effective as of Jan. 1, will be reported as a part of Neogen’s animal safety segment. Terms of the acquisition were not disclosed. Neogen plans to retain Scidera’s current employees and continue to operate from the company’s facilities in Davis.
